Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang(®) SR and Glucophage(®) XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial

OBJECTIVE: The purpose of this single-center, randomized, open, two-period, two-sequence crossover, single-dose administration, bioequivalence research was to evaluate the bioequivalence and safety of the generic formulations of metformin hydrochloride sustained-release (MH-SR) 500 mg tablets (test...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ming-Li, Liu, Hui-Juan, Luo, Xiang-Dong, Wang, Yu, Zhang, Wei, Liu, Chen, Wang, Xinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885941/
https://www.ncbi.nlm.nih.gov/pubmed/35061235
http://dx.doi.org/10.1007/s40268-021-00377-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885941/
https://www.ncbi.nlm.nih.gov/pubmed/35061235
http://dx.doi.org/10.1007/s40268-021-00377-w

Ejemplares similares